一种与肠道病毒相关的新的疾病——“纸坊”病病因的研究

1985年4月至10月,贵州省沿河县大漆乡纸坊村发生了病因不明的流行病。全村约1/5的人发病,起病急,轻症者表现为头晕,乏力,肌痛,多汗,心悸,伴以低热(38℃以下)。部份病人起病初期有短暂的腹泻,为稀便,无脓血。重症者具有高热(40℃以上),大汗,心悸,游走性肌索痉挛性隆起,伴有明显触痛,以腰骶部及四肢肌肉为多发部位,病人烦燥     

红斑性肢痛症相关痘病毒血清免疫学特征的研究

本文从四个方面综合报道了红斑性肢痛症相关痘病毒(ERPV)血清免疫学特征的研究结果。血清学鉴定表明,ERPV为正痘病毒属内成员,但与正痘病毒属内成员痘苗病毒和鼠痘病毒具有中和抗原表位差异。流行性红斑性肢痛症患者血清中含有抗ERPV的中和抗体和抗ERPVA型包涵体IgG抗体,其检出率明显高于当地未发病者和美国人群的检出率。     

一起传染病暴发中肠道病毒血清型鉴定和ECHO30基因特征分析

2003年5～9月,山东省泰安市发生了由肠道病毒(Enterovirus,EV)感染所致的传染病暴发,临床症状以手足口病(HFMD)为主,同时有心肌炎和无菌性脑膜炎等中枢神经系统症状患者也占较大比例。131份病人(粪便、咽拭子、脑脊液)标本中共分离到EV62株,其中ECHO1939株,EV716株,ECHO304株,其它肠道病毒13株。4株ECHO30病毒中的2株分离自2个患者的粪便标本,但用WHO肠道组合血清中和试验未能定出型别。另外2株分离自同一患者的粪便和脑脊液标本。病原学分析表明,ECHO30是引起该患者无菌性脑膜炎的病原。抗E—CHO30标准株的血清中和这4株病毒的滴度低于标准株5～20倍。VP1区全基因序列测定和同源性比较分析表明,4株ECHO30分离株病毒核苷酸同源性在98．0％～98．5％,氨基酸同源性在98．9％～99．3％,提示这4株病毒来源于同一传播链,2003年5～9月ECHO30在该地区可能有局部流行。系统进化树分析表明,ECHO30病毒可以划分为6个基因型,其中基因型1～5为GenBank中已发表的ECHO30分离株,山东分离株与其它5个基因型成员核苷酸差异分别在9．4％～24．4％,在进化树上形成了较独立的分支,是一个新基因型,将其划分为第6基因型。     

急性弛缓性麻痹病例中ECHO11病毒的基因特征分析

该文首次分析了我国ECHO11病毒的分子流行病学资料。1999~2004年,ECHO11病毒是山东省急性弛缓性麻痹(AFP)病例中分离到的优势毒株,2003年从山东省482例AFP病例中共分离到11株ECHO11病毒,其中相关的10例病例分布跨越山东省大部分地区,但发病日期集中在7月和12月。该研究试图通过对VP1编码基因全序列的测定和分析,为探讨ECHO11病毒与AFP之间的病因关系提供线索。分子流行病学研究提示,11株E-CHO11毒株都位于同一传播链,核苷酸同源性为97.2%~100%,氨基酸同源性为99.6%~100%,其中7月和12月的分离株之间相差8~9个核苷酸,氨基酸序列一致。这说明山东省2003年7月和12月分别发生了ECHO11病毒流行,但这些毒株与AFP的病因关系尚需进一步研究。11株病毒组成了A基因型中的一个新亚型,在进化树上单独呈密切相关的一簇,与同基因型内的其它亚型的核苷酸同源性为82.2%~84.7%,氨基酸同源性为94.8%~97.6%。     

人嗜T淋巴细胞Ⅰ型病毒(HTLV-Ⅰ)与神经系统疾病关系的初步研究

1980年,美国的Poiesy和日本的Miyoshi等先后发现人类第一个C型逆转录病毒,后国际上统一命名为人嗜T淋巴细胞Ⅰ型病毒(HTLV-1)。这类病毒以人T_4细胞亚群为靶细胞,并与成人T细胞白血病有病原学关系。1985年,Gessain等报告在热痉挛性瘫痪病人(Tropical Spastic Paraparesis,TSP)血清和脑脊液中查出HTLV-Ⅰ抗体,1986年又在Colombia、Jamaica、Trinidad、Tobago和Ivory Coast等一些国家和地区,也发现某些慢性脊髓神经病变患者(症状相似于TSP病人)的血清和脑脊液中有HTLV-Ⅰ抗体存在。     

埃可病毒25型新型中和实验方法的建立与应用

目的:建立一种新型的快速、高通量的埃可病毒25型(ECHO25)中和抗体检测方法,并初步评价其在ECHO25中和抗体筛选和血清流行病学调查中的应用价值。方法:应用免疫荧光方法筛选ECHO25高亲和性抗体并将其作为检测单抗,结合酶联免疫斑点检测技术(ELISPOT)建立ECHO25中和抗体检测方法;使用不同效价的血清评价该方法的准确性;采用所建立的中和方法对ECHO25单克隆抗体、临床血清样品进行检测。结果:建立了快速检测ECHO25中和抗体的Nt-ELISPOT方法,以ECHO25单克隆抗体5B9作为检测抗体;相比经典的中和实验方法 Nt-CPE,该方法可显著缩短检测时间(从5~7 d缩短至1 d以内),检测结果具有较好的一致性;采用所建立的Nt-ELISPOT方法首次筛选获得3株对ECHO25具有较好中和能力的单克隆抗体;临床血清样品检测结果显示厦门地区可能存在ECHO25的流行。结论:该方法可以应用于中和抗体筛选和血清学的临床辅助诊断,为ECHO25的防治研究提供支持。     

肠道病毒ECHO20血清型鉴定和VP1序列初步分析

肠道病毒(Enterovirus)是最常见的人类致病病毒之一,包括脊髓灰质炎病毒、柯萨奇A组病毒、柯萨奇B组病毒和ECHO病毒.一般认为大多数肠道病毒感染症状轻微或不明显,然而有时肠道病毒感染也可能是严重甚至致命的[1].2004年云南省潞西县局部地区发生小规模的甲肝流行,我们从当地部分患者粪便标本中分离到多株甲肝病毒,同时,经过肠道病毒组合血清和单价血清的中和试验,证明患者为甲肝和ECHO20病毒双重感染.通过文献检索我们发现,国内对ECHO20病毒的相关研究极少,且多限于病毒的血清学分离鉴定,而对其重要的衣壳蛋白编码基因vp1的测定和分析尚未见报道,为阐明ECHO20分离株的分子流行病学特征,分析其基因变异规律,探讨我国分离株和国外分离株的区别和联系,我们测定了编码重要抗原决定簇的整个vp1序列,并和GenBank中已有的ECHO20病毒vp1基因序列进行了比较分析.     

人集落刺激因子-1(CSF-1)对常见呼吸道病毒的抑制作用

本文观察集落刺激因子-1(CSF-1)及其诱生剂:内毒素(LPS)、胞壁二肽(MDP)和干扰素(IFN-α)对下列病毒所致细胞病变的抑制,包括不同型别腺病毒5株,单疱病毒Ⅰ型和Ⅱ型,流感病毒A_3型,鼻病毒,ECHO11型各1株,在人胚肺传代细胞株上病变抑制的结果如下:对HSV-1、HSV-2、腺病毒6、11、22型,流感A_3型,鼻病毒。(CSF-1)和IFN-α,一样有明显抑毒效果,LPS MDP联合使用对以上病毒有明显增强抑毒作用。CSF-1和IFN-α的抑毒作用能分别被CSF-1和IFN-α的抗体所解除。 CSF-1在人胚肺传代细胞和人胚皮肤肌肉传代细胞上对VSV的抑毒效果在人胚肺细胞中效果比人胚皮肤肌肉细胞更明显。LPS10ng/ml作用48小时比作用24小时效果更强。LPS MDP和IFN-α对二种细胞都有同样高效的抑毒作用。     

肠道病毒ECHO13中国分离株的基因特征

为研究ECHO13病毒中国分离株的分子特征及其与世界其它分离株之间的基因关系,对1998年、2000年从中国福建省分离到2株ECHO13病毒进行基因序列对比分析.2株病毒分别命名为Fujian98-1和Fujian00-1,用逆转录-聚合酶链反应(RT-PCR)扩增出VP1蛋白编码基因全长861个核苷酸片段并进行序列测定,将2株ECHO13病毒的VP1序列与所有已发表的ECHO13病毒VP1基因全长进行同源性比较.结果显示,福建分离株之间核苷酸同源性为79.6%,氨基酸同源性为93.4%;与遗传距离最近的法国CF1089-91(AJ537604)毒株的核苷酸同源性分别为80%和88%,与代表株Del Carmen的核苷酸同源性分别为75.8%和77.9%.通过VP1基因分析,福建2株病毒均属于ECHO13病毒,与血清中和试验鉴定结果一致.下载所有已发表的ECHO13病毒VP1序列并构建进化树,发现福建2株病毒分属不同的分枝,提示这2株病毒来自不同的病毒传播链.进一步分析发现,整个ECHO13病毒可划分为3个不同的基因型:A、B和C基因型.福建Fujian98-1和Fujian00-1分别被划分在基因型B和C中,各基因型之间的核苷酸差异均大于20%.为验证该分型方法,将26株来自不同国家和时间的ECHO13病毒和2株福建分离ECHO13病毒部分VP1基因序列进行对比分析,建立进化树.结果显示,所有ECHO13病毒被分在A、B和C3个基因型中,而2株福建分离病毒仍然被分在B和C基因型中.除了B基因型1株病毒以外,所有3个基因型之间的核苷酸差异均大于15%,与VP1全长分型结果基本一致,说明部分VP1序列的基因分析也能用于对ECHO13病毒进行规律和分子流行病学的研究中.该研究首次报道了ECHO13病毒中国分离株的VP1蛋白基因全长序列,并推荐按VP1基因全长核苷酸差异≥20%作为划分基因型的标准,将已知的ECHO13病毒划分为A、B和C3个基因型.同时也可用病毒VP1基因5′端部分序列替代VP1全长序列来划分基因型.     

犬瘟热病毒H蛋白基因重组腺病毒的构建及免疫效果评估

研究选取犬瘟热病毒H蛋白基因为目的基因,利用反转录聚合酶链式反应(RT-PCR)、酶切、连接等方法构建出重组人5型腺病毒穿梭质粒和骨架质粒,两者共转染293AD细胞并包装出重组腺病毒。通过电镜负染、酶切鉴定、Western blot及一步生长曲线测定等方法进行病毒的生物学特性鉴定,证明犬瘟热病毒H蛋白基因重组腺病毒构建正确。犬分别肌肉接种CDV疫苗毒和重组腺病毒,并检测免疫后第14,28,42,56,70,84d时犬血清中抗CDV中和抗体的变化情况。结果显示,犬免疫重组腺病毒后体内产生的抗CDV平均中和抗体水平高于对照组,滴度最高达2-8。研究表明,正确构建的重组腺病毒具有良好的免疫原性,诱导产生的抗犬瘟热病毒中和抗体达到犬最低免疫保护水平,为进一步研发犬瘟热病毒活载体疫苗提供理论依据。     

Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus

Anticomplement immunofluorescence (ACIF) was tested for its use for the titration of antibody against varicella-zoster virus (VZV). ACIF antibody responses of patients with VZV infection were specific for VZV antigen and heterotypic responses to herpes simplex virus type-1 and cytomegalovirus antigens were not observed. Comparative studies of ACIF, membrane immunofluorescence (MIF) and indirect immunofluorescence (IF), using acetone-fixed antigen, were carried out with nonimmune sera and convalescent sera of patients who had recovered from varicella, herpes zoster and Rumsey Hunt disease. Nonspecific staining occurred with some nonimmune sera at a 1:4 dilution in the MIF and IF tests, after freezing and thawing of the serum, but not in the ACIF test. The antibody titers in convalescent sera agreed well in these three methods and the highest titer was obtained by MIF. The titers in ACIF and IF were similar but the ACIF antibody decreased earlier than the IF antibody during convalescence. On the other hand there was a discrepancy between the titers of ACIF and those of MIF and IF antibody in the sera of healthy adults, all sera with titers higher than 10 in the MIF and IF tests had titers below 10 in the ACIF test. The average titer of ACIF antibody declined to less than 10 with increasing age (13 to more than 20 years), whereas the MIF antibody increased during the same period of life.     

从广州市散发性脑炎病人血清中查出雪鞋野兔病毒抗体升高

近几年来夏季,在我国南方一些省市发现一些散发性病毒性脑炎病例,主要是儿童。他们的流行性乙型脑炎抗体阴性。病因不明。 为了研究本病的病因,于1983年4月至10月,我们在广州市儿童医院收集了34例散发性脑炎病人的双份血清,15例其它病种(如百日咳、心肌炎、钩端螺旋体脑炎、多发性神经根     

Further Isolation of a Recombinant Virus (H1N2, Formerly Hsw1N2) from a Pig in Japan in 1980

In September 1980, an outbreak of febrile respiratory disease was observed in a herd of sows (1-2 years of age) in Ehime Prefecture, Japan. Most of the swine showed clinical signs of disease such as depression, anorexia, fever, nasal discharge, and cough. A hemagglutinating agent was isolated from a nasal swab from one of the diseased pigs. By cross-hemagglutination-inhibition and neuraminidase-inhibition tests with antisera to influenza viruses of swine origin, the isolate was identified as an influenza A virus of the H1N2 (former designation, Hsw1N2) subtype, and designated A/swine/Ehime/1/80 (H1N2). Significant antibody rises against the surface antigens of the isolate were found in convalescent swine sera. The distribution of antibody against H1N2 virus in swine sera in Ehime Prefecture was examined. Seven (8%) of 93 sera collected after the outbreak (in 1981) showed antibodies to only H1 and N2 antigens but none of the sera before the outbreak contained such antibodies, indicating that H1N2 virus had been restrictedly prevalent among swine but was not wide-spread until 1981.     

Evaluation of an immunoenzyme test (ELISA) for the determination of an Ag/Ab system correlated to non-A, non-B post-transfusion hepatitis

An ELISA for the detection of a Ag/Ab system related to non-A, non-B post-transfusion hepatitis (NANB-PTH) has been developed. A convalescent serum from a patient suffering, 14 month before, of NANB-PTH was used both as capture and detector antibody in a "sandwich" type immunoassay to detect an Ag (Ag-NANB). A "blocking" immunoassay was used, in the same test, to detect the corresponding antibody (Ab-NANB). All patients with NANB-PTH were positive, alternately, for Ag-NANB or Ab-NANB. The Ag was found in the acute phase sera of 3 out of 22 cases of NANB-PTH (13,6%), but in none of 29 acute hepatitis type B,26 acute hepatitis type A,14 NANB sporadic hepatitis, 5 infectious mononucleosis and 8 healthy subjects. 2/3 Ag-NANB positive subjects became chronic carriers of this Ag, whereas the third seroconverted for Ab-NANB after the first two months of their disease. Furthermore, a significant increase of the Ab-NANB titer was observed in the convalescent phase of the disease in 18/20 NANB-PTH. As expected, a relatively high prevalence for Ab-NANB was found in the other groups of patients, suggesting the high diffusion of the agent, but none of these subjects showed a progressive increase of the antibody titer during the course of their disease.     

Rapid Laboratory Diagnosis of an Outbreak of Influenza

The specific diagnosis of an outbreak of acute febrile disease in a sanatorium ward was made rapidly by examining sera from the nine patients for antibodies to a series of likely viruses. All eight convalescent cases had high antibody levels to Influenza A2 (Asian) virus and the case at the acute stage had none. This serological diagnosis provided the first information that influenza was present in the area. Later, Influenza virus Type A2 was grown from the acute case.     

北京市手足口病的病原学研究

1984年北京手、足、口病流行时,采集了18例病人的皮疱液标术。用乳小白鼠作病毒分离,10份阳性,鉴定为阿萨奇A16型病毒(CoxA16)。双份血清标本中和抗体测定结果亦证明为CoxA18感染。     

Molecular characterization and phylogenetic analysis of enteroviruses inducing the outbreaks and seasonal rises of morbidity in different regions of the Republic of Belarus

As shown by the results of the analysis, viruses ECHO 30 circulating over the period of the last 8 years in Belarus, belonged to 3 different genetic subtypes which earlier or simultaneously circulated in other European states. The outbreaks of enterovirus infections (EVI) were facilitated by the appearance of a genetic viral subtype, relatively "new" for human population, and which had not earlier circulated on this territory. Thus, the development of outbreak morbidity in 2003 was caused by a change in the dominating subtype of virus ECHO 30, which caused the outbreak of 1997. The relatively "soft" rise of morbidity in 2004 was due to the continued circulation of the same subtype of virus ECHO 30, that in 2003. The largest outbreaks of EVI in the Republic of Belarus had a number of considerable differences: the outbreak of 1997 in Gomel was characterized by the genetic heterogeneity of infective agents, being simultaneously geographically localized within the limits of one city. However, during the outbreaks of 2003 the circulation of genetically closely related viruses of the one subtype among the population of geographically remote regions of the country was registered.     

A clustering outbreak of hand, foot, and mouth disease caused by Coxsackie virus A10

A clustering outbreak of hand, foot, and mouth disease (HFMD) occurred from July, 1981 to January, 1982 in Matsue City and Gotsu City, Shimane Prefecture. Thirty-seven patients with clinical HFMD were virologically and serologically examined, and Coxsackie virus A10 (CA10) was isolated in 18 patients from vesicles (7/16), throat-swabs (9/31) and feces (6/7). During the period, no CA16 or enterovirus 71 were isolated from HFMD patients or from other diseases such as pharyngitis, febrile diseases, and aseptic meningitis. Serological diagnosis was performed employing an African green monkey kidney cell (AG-1)-adapted CA10 which demonstrated cytopathogenic effects on the cells. Paired sera from seven patients including three cases in which isolation failed showed a significant increase of neutralizing antibody titer against CA10. Finally, an etiological diagnosis was made in 21 out of 37 patients with clinical HFMD. This is the first report of a clustering outbreak of HFMD caused by CA10 in Japan.